Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rocuronium versus suxamethonium for rapid sequence induction in patients aged 80 years or older
2020-005384-31Phase 4Completed
- Sponsor
- Rigshospitalet
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial comparing Rocuronium with Suxamethonium (2 arms). Primary endpoint: Proportion with excellent intubation conditions. Started Dec 2020; status: completed.
02
Drugs
rocuroniumsuccinylcholine
Beyond the preview
Go deeper on 2020-005384-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-005384-31.